These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7905592)

  • 21. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.
    King JT; O'Byrne M; Vasquez M; Wright D;
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):784-93. PubMed ID: 26384639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed Nicolau's livedoid dermatitis after ultrasound-guided sclerotherapy.
    Ramelet AA; Parmentier L
    Dermatol Surg; 2010; 36(1):155-8. PubMed ID: 19889155
    [No Abstract]   [Full Text] [Related]  

  • 23. [A young woman with skin necrosis after sclerotherapy].
    Bieleveld LM; Aldenzee MJ
    Ned Tijdschr Geneeskd; 2015; 159():A9074. PubMed ID: 26230344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polidocanol: the perfect "solution".
    Weiss RA
    J Dermatol Surg Oncol; 1994 Jul; 20(7):465. PubMed ID: 8034841
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anaphylaxis following use of polidocanol].
    Stricker BH; van Oijen JA; Kroon C; Ovink AH
    Ned Tijdschr Geneeskd; 1990 Feb; 134(5):240-2. PubMed ID: 2304580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of varicose tributaries with sclerotherapy with polidocanol 0.5 % foam.
    Reich-Schupke S; Weyer K; Altmeyer P; Stücker M
    Vasa; 2010 May; 39(2):169-74. PubMed ID: 20464673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polidocanol-foam treatment of varicose veins: Quality-of-life impact compared to conventional surgery.
    Sakugawa LS; Portela FSO; Louzada ACS; Portugal MFC; Teivelis MP; Mendes CA; Pinheiro LL; Silva MFAD; Fioranelli A; Wolosker N
    Clinics (Sao Paulo); 2024; 79():100346. PubMed ID: 38574572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late stroke after foam sclerotherapy.
    Hahn M; Schulz T; Jünger M
    Vasa; 2010 Feb; 39(1):108-10. PubMed ID: 20186684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of Aethoxysklerol® (polidocanol) 0.5%, 1% and 3% in comparison with placebo solution for the treatment of varicose veins of the lower extremities in Chinese patients (ESA-China Study).
    Zhang J; Jing Z; Schliephake DE; Otto J; Malouf GM; Gu YQ
    Phlebology; 2012 Jun; 27(4):184-90. PubMed ID: 22045827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation.
    Marrocco-Trischitta MM; Guerrini P; Abeni D; Stillo F
    Dermatol Surg; 2002 Feb; 28(2):153-5. PubMed ID: 11860427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1% polidocanol.
    Künzlberger B; Pieck C; Altmeyer P; Stücker M
    Dermatol Surg; 2006 Nov; 32(11):1410-3. PubMed ID: 17083597
    [No Abstract]   [Full Text] [Related]  

  • 32. Sclerotherapy and foam sclerotherapy for varicose veins.
    Coleridge Smith P
    Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Foam sclerotherapy for spouting haemorrhage in patients with varicose veins.
    Hamahata A; Yamaki T; Osada A; Fujisawa D; Sakurai H
    Eur J Vasc Endovasc Surg; 2011 Jun; 41(6):856-8. PubMed ID: 21420881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transparietal diffusion of polidocanol: Potential complication of sclerotherapy?
    Ramelet AA; Bossart S
    Phlebology; 2023 Dec; 38(10):698-699. PubMed ID: 37644640
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: Polidocanol concentration and time affect the properties of foam used for sclerotherapy.
    Cameron E
    Dermatol Surg; 2012 Feb; 38(2):290. PubMed ID: 22309639
    [No Abstract]   [Full Text] [Related]  

  • 36. Reducing hyperpigmentation after sclerotherapy: A randomized clinical trial.
    Gonzalez Ochoa AJ; Carrillo J; Manríquez D; Manrique F; Vazquez AN
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):154-162. PubMed ID: 32739509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial.
    Bertanha M; Sobreira ML; Pinheiro Lúcio Filho CE; de Oliveira Mariúba JV; Farres Pimenta RE; Jaldin RG; Moroz A; Moura R; Rollo HA; Yoshida WB
    Trials; 2014 Dec; 15():497. PubMed ID: 25527165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
    Todd KL; Wright DI;
    Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sclerotherapy: review of results and complications in 200 patients.
    Puissegur Lupo ML
    J Dermatol Surg Oncol; 1989 Feb; 15(2):214-9. PubMed ID: 2915088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up.
    Moreno-Moraga J; Smarandache A; Pascu ML; Royo J; Trelles MA
    Phlebology; 2014 Dec; 29(10):658-66. PubMed ID: 23989971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.